Fairmount Advises Cambridge Biomedical in Acquisition by BioAgilytix

DURHAM, N.C. – November 4, 2019 – BioAgilytix, a leading provider of large molecule bioanalytical testing services, today announced that it has acquired Cambridge Biomedical, a contract research organization based in the Cambridge area of Massachusetts, which also specializes in large molecule bioanalysis. The transaction expands BioAgilytix’s global footprint into the heart of the world’s […]